Medici Therapeutics, Inc. — Form D
Medici Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-04. The offering totals $14.8M, of which $14.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-04
- Form: D
- Accession: 0002097084-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.8M
- Amount sold: $14.8M
- Investors: 11
- Date of first sale: 2025-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-565786
Issuer
- Name: Medici Therapeutics, Inc.
- CIK: 0002097084
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 230 COMMONWEALTH AVENUE, BOSTON, MA, 02116
- Phone: 407-733-2808
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Denitsa Milanova | Director | Boston, MA |
| Matthew P Rabinowitz | Director | Boston, MA |
| Denitsa Milanova | Executive Officer | Boston, MA |
| Nicholas P Restifo | Executive Officer | Boston, MA |
| David Thompson | Executive Officer | Los Angeles, CA |
More